Insmed shares are trading lower after the company reaffirmed its FY26 revenue guidance. Also, CFO Sara Bonstein will step down.
Insmed shares are trading lower after the company reaffirmed its FY26 revenue guidance. Also, CFO Sara Bonstein will step down.